Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial | Zendy

Eva Versteijne | Zendy; Mustafa Suker | Zendy; Karin Groothuis | Zendy; Janine M. Akkermans-Vogelaar | Zendy; Marc G. Besselink | Zendy; Bert A. Bonsing | Zendy; Jeroen Buijsen | Zendy; Olivier R. Busch | Zendy; Geert-Jan Creemers | Zendy; Ronald M. van Dam | Zendy; Ferry A.L.M. Eskens | Zendy; Sebastiaan Festen | Zendy; Jan Willem B. de Groot | Zendy; Bas Groot Koerkamp | Zendy; Ignace H. J. T. de Hingh | Zendy; Marjolein Y.V. Homs | Zendy; Jeanin E. van Hooft | Zendy; Emile D. Kerver | Zendy; Saskia Luelmo | Zendy; Karen J. Neelis | Zendy; Joost J. Nuyttens | Zendy; Gabriel Paardekooper | Zendy; Gijs A. Patijn | Zendy; Maurice J.C. van der Sangen | Zendy; Judith de VosGeelen | Zendy; Johanna W. Wilmink | Zendy; Aeilko H. Zwinderman | Zendy; Cornelis J.A. Punt | Zendy; Casper H.J. van Eijck | Zendy; Geertjan van Tienhoven | Zendy

Open Access

Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial

Author(s) -

Eva Versteijne,

Mustafa Suker,

Karin Groothuis,

Janine M. Akkermans-Vogelaar,

Marc G. Besselink,

Bert A. Bonsing,

Jeroen Buijsen,

Olivier R. Busch,

Geert-Jan Creemers,

Ronald M. van Dam,

Ferry A.L.M. Eskens,

Sebastiaan Festen,

Jan Willem B. de Groot,

Bas Groot Koerkamp,

Ignace H. J. T. de Hingh,

Marjolein Y.V. Homs,

Jeanin E. van Hooft,

Emile D. Kerver,

Saskia Luelmo,

Karen J. Neelis,

Joost J. Nuyttens,

Gabriel Paardekooper,

Gijs A. Patijn,

Maurice J.C. van der Sangen,

Judith de VosGeelen,

Johanna W. Wilmink,

Aeilko H. Zwinderman,

Cornelis J.A. Punt,

Casper H.J. van Eijck,

Geertjan van Tienhoven

Publication year - 2020

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.19.02274

Subject(s) - medicine , gemcitabine , chemoradiotherapy , hazard ratio , surgery , randomized controlled trial , pancreatic cancer , survival rate , perineural invasion , clinical endpoint , radiation therapy , cancer , chemotherapy , confidence interval

Preoperative chemoradiotherapy may improve the radical resection rate for resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research